BRIEF published on 04/21/2026 at 15:14, 23 days 19 hours ago MaaT Pharma SACA maintient sa recommandation d'achat avec des perspectives financières stables Performance Financière Développement De Pipelines MaaT Pharma Dossier D'investissement Évaluation D'achat
BRIEF published on 04/21/2026 at 15:14, 23 days 19 hours ago MaaT Pharma SACA Maintains Buy Rating with Stable Financial Outlook Financial Performance BUY Rating Pipeline Development MaaT Pharma Investment Case
PRESS RELEASE published on 04/21/2026 at 15:09, 23 days 19 hours ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research reaffirms Buy rating for MaaT Pharma SACA with a target price of €17 following FY25 results and pipeline update. No changes to core investment case First Berlin Equity Research BUY Rating MaaT Pharma SACA FY25 Results €17 Target Price
BRIEF published on 04/01/2026 at 07:35, 1 month 14 days ago MaaT Pharma publishes data on aGvH in "Bone Marrow Transplantation" MaaT Pharma EMA AGvH Xervyteg® CHRONOS
BRIEF published on 04/01/2026 at 07:35, 1 month 14 days ago MaaT Pharma Presents CHRONOS Study Results on Third-Line Acute GvHD MaaT Pharma Regulatory Review CHRONOS Study Acute GvHD Third-line Therapy
BRIEF published on 04/01/2026 at 07:35, 1 month 14 days ago MaaT Pharma présente les résultats de l'étude CHRONOS sur le traitement de troisième ligne de la GVHD aiguë MaaT Pharma Examen Réglementaire Étude CHRONOS GVHD Aiguë Traitement De Troisième Ligne
BRIEF published on 04/01/2026 at 07:35, 1 month 14 days ago MaaT Pharma publie des données sur l'aGvH dans "Bone Marrow Transplantation" MaaT Pharma EMA AGvH Xervyteg® CHRONOS
PRESS RELEASE published on 04/01/2026 at 07:30, 1 month 14 days ago Informations privilégiées / Autres communiqués MaaT Pharma publie des données rétrospectives de l'étude CHRONOS sur la maladie aiguë du greffon contre l'hôte (aGvH) dans Bone Marrow Transplantation. Résultats présentés au congrès annuel 2026 de l'EBMT MaaT Pharma Étude Bone Marrow Transplantation CHRONOS Maladie Aiguë Du Greffon Contre L'hôte
PRESS RELEASE published on 04/01/2026 at 07:30, 1 month 14 days ago Inside Information / Other news releases MaaT Pharma announces publication of retrospective data from CHRONOS study in Bone Marrow Transplantation Journal, presenting real-world outcomes of third-line systemic treatments for GI-aGvHD patients MaaT Pharma GI-aGvHD CHRONOS Study Retrospective Data Bone Marrow Transplantation
BRIEF published on 03/31/2026 at 07:35, 1 month 15 days ago MaaT Pharma: 2025 Revenue and Clinical Progress Revenue Funding Clinical Development MaaT Pharma Microbiothérapies
Published on 05/15/2026 at 09:01, 1 hour 17 minutes ago Apex Drills 23.1 m of 3.47% REO Within Broader Zone of 137.2 m at 2.01% REO, Extending Mineralization 180 m in Western Step-Out at the Rift Rare Earth Project
Published on 05/15/2026 at 08:00, 2 hours 18 minutes ago Interim Results For The Three Months Ended March 31, 2026
Published on 05/15/2026 at 08:00, 2 hours 18 minutes ago Caledonia Mining Corporation Plc: Non-Executive Director Shareholding Notification
Published on 05/15/2026 at 01:35, 8 hours 43 minutes ago NXT Energy Solutions Announces First Quarter 2026 Results
Published on 05/15/2026 at 01:30, 8 hours 48 minutes ago Nano One Reports Q1 2026 Results and Reminds Shareholders of Upcoming AGM
Published on 05/15/2026 at 10:00, 18 minutes ago Invitation to the 19th International Investment Forum (IIF) on May 20, 2026 – Digital Focus on Global Growth Stocks
Published on 05/15/2026 at 09:58, 20 minutes ago Original-Research: init innovation in traffic systems SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/15/2026 at 09:56, 22 minutes ago EQS-Adhoc: centrotherm international AG: Centrotherm AcquiCo AG submits specified request for the squeeze-out of mi-nority shareholders of centrotherm international AG
Published on 05/15/2026 at 09:35, 42 minutes ago H&R GmbH & Co. KGaA publishes Interim Report Q1/2026 and confirms Preliminary Figures
Published on 05/15/2026 at 09:30, 48 minutes ago Nagarro presents Q1 2026 numbers, posts 6.5% YoY revenue growth in constant currency
Published on 05/15/2026 at 10:09, 8 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 1 hour ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day 16 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
